INT53316

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.65
First Reported 1994
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 5
Total Number 5
Disease Relevance 1.59
Pain Relevance 1.32

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cofactor metabolic process (Ppt1) Golgi apparatus (Ppt1) cytosol (Ppt1)
extracellular space (Ppt1) protein modification process (Ppt1) extracellular region (Ppt1)
Anatomy Link Frequency
cervical region 1
nerves 1
PPT 1
Ppt1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Pain 20 98.20 Very High Very High Very High
withdrawal 1 93.96 High High
Hyperalgesia 12 80.16 Quite High
antinociception 5 79.92 Quite High
Stimulus evoked pain 3 60.56 Quite High
tetrodotoxin 1 51.20 Quite High
headache 6 50.00 Quite Low
Pain threshold 2 50.00 Quite Low
Opioid 20 25.64 Quite Low
Glutamate 1 25.00 Low Low
Disease Link Frequency Relevance Heat
Neck Pain 6 98.20 Very High Very High Very High
Pain 18 87.04 High High
Headache 6 82.36 Quite High
Hyperalgesia 26 80.16 Quite High
Nociception 8 78.68 Quite High
Stress 12 71.60 Quite High
Hypersensitivity 3 60.16 Quite High
Neuralgia 1 50.00 Quite Low
Inflammatory Pain 10 5.00 Very Low Very Low Very Low
INFLAMMATION 9 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The magnitude of PPT decreases was greater in the cervical region as compared to the trigeminal region (P < .01).
Localization (decreases) of PPT in cervical region
1) Confidence 0.65 Published 2010 Journal J Pain Section Abstract Doc Link 19945351 Disease Relevance 1.13 Pain Relevance 1.07
There was a greater magnitude of PPT decrease within trigeminal nerves as compared with nontrigeminal nerves (P < .03).
Localization (decrease) of PPT in nerves
2) Confidence 0.65 Published 2010 Journal Pediatrics Section Body Doc Link 20530075 Disease Relevance 0.07 Pain Relevance 0
RESULTS: CTTH patients showed decreased PPT and increased tenderness as compared with controls (P<0.001).
Localization (decreased) of PPT
3) Confidence 0.64 Published 2007 Journal Clin J Pain Section Body Doc Link 17449996 Disease Relevance 0.24 Pain Relevance 0
PPT stimulation evoked release was also high when the cortical probe was perfused with atropine plus neostigmine, but it was not increased any further by systemic scopolamine or by scopolamine perfused through the NBM probe.
Localization (release) of PPT in PPT
4) Confidence 0.59 Published 1994 Journal Can. J. Physiol. Pharmacol. Section Abstract Doc Link 7834577 Disease Relevance 0 Pain Relevance 0.05
In the time-course experiments PPT were measured at 4 days after CFA before and at 2-96 h after vector injections.
Localization (measured) of PPT
5) Confidence 0.23 Published 2009 Journal Mol Pain Section Body Doc Link PMC2797781 Disease Relevance 0.15 Pain Relevance 0.20

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox